Vivos Therapeutics Statistics
Total Valuation
VVOS has a market cap or net worth of $7.33 million. The enterprise value is $6.60 million.
Market Cap | 7.33M |
Enterprise Value | 6.60M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, after market close.
Earnings Date | May 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
VVOS has 3.23 million shares outstanding. The number of shares has increased by 132.99% in one year.
Shares Outstanding | 3.23M |
Shares Change (YoY) | +132.99% |
Shares Change (QoQ) | +62.58% |
Owned by Insiders (%) | 6.77% |
Owned by Institutions (%) | 12.97% |
Float | 2.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.55 |
Forward PS | 0.43 |
PB Ratio | 12.59 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.49 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 3.23.
Current Ratio | 0.45 |
Quick Ratio | 0.39 |
Debt / Equity | 3.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,989.60% and return on invested capital (ROIC) is -646.51%.
Return on Equity (ROE) | -1,989.60% |
Return on Assets (ROA) | -134.30% |
Return on Capital (ROIC) | -646.51% |
Revenue Per Employee | $117,219 |
Profits Per Employee | -$137,219 |
Employee Count | 114 |
Asset Turnover | 1.15 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.82% in the last 52 weeks. The beta is 7.99, so VVOS's price volatility has been higher than the market average.
Beta (1Y) | 7.99 |
52-Week Price Change | -76.82% |
50-Day Moving Average | 3.22 |
200-Day Moving Average | 6.34 |
Relative Strength Index (RSI) | 40.37 |
Average Volume (30 Days) | 178,704 |
Short Selling Information
The latest short interest is 62,778, so 1.95% of the outstanding shares have been sold short.
Short Interest | 62,778 |
Short Previous Month | 191,083 |
Short % of Shares Out | 1.95% |
Short % of Float | 3.14% |
Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, VVOS had revenue of $13.36 million and -$15.64 million in losses. Loss per share was -$10.93.
Revenue | 13.36M |
Gross Profit | 7.87M |
Operating Income | -15.93M |
Pretax Income | -15.64M |
Net Income | -15.64M |
EBITDA | -15.05M |
EBIT | -15.64M |
Loss Per Share | -$10.93 |
Balance Sheet
The company has $2.61 million in cash and $1.88 million in debt, giving a net cash position of $729,000 or $0.23 per share.
Cash & Cash Equivalents | 2.61M |
Total Debt | 1.88M |
Net Cash | 729,000 |
Net Cash Per Share | $0.23 |
Equity / Book Value | 582,000 |
Book Value Per Share | 0.18 |
Working Capital | -4.46M |
Cash Flow
In the last 12 months, operating cash flow was -$10.92 million and capital expenditures -$715,000, giving a free cash flow of -$11.64 million.
Operating Cash Flow | -10.92M |
Capital Expenditures | -715,000 |
Free Cash Flow | -11.64M |
FCF Per Share | -$5.04 |
Margins
Gross margin is 58.90%, with operating and profit margins of -119.21% and -117.06%.
Gross Margin | 58.90% |
Operating Margin | -119.21% |
Pretax Margin | -117.06% |
Profit Margin | -117.06% |
EBITDA Margin | -112.63% |
EBIT Margin | -117.06% |
FCF Margin | -87.09% |
Dividends & Yields
VVOS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -132.99% |
Shareholder Yield | -132.99% |
Earnings Yield | -213.53% |
FCF Yield | -158.86% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 27, 2023. It was a reverse split with a ratio of 1:25.
Last Split Date | Oct 27, 2023 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
VVOS has an Altman Z-Score of -14.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -14.79 |
Piotroski F-Score | 3 |